Liver function effects of SGLT2 inhibitor and GLP-1 receptor agonist combination treatment in patients with type 2 diabetes (post hoc analysis of RECAP study)
In exploratory research, retatrutide represents the most ambitious incretin agent currently available
In this comprehensive article, we will explore what GLP-1 is, how it was discovered, where it is produced in the body, its effects and half-life, and why it has become the most promising target in pharmaceutical weight loss
This additional fat-burning mechanism is one of the key reasons retatrutide has demonstrated greater weight loss in clinical trials compared to treatments that target fewer receptors
Eventually, it leads to uptake of glucose by the body cells and decreasing the level in the blood
Monitoring and titration If you are microdosing GLP-1 medications, it is important to track the side effects carefully, particularly gastrointestinal side effects such as nausea, vomiting, diarrhea, and constipation
:max_bytes(150000):strip_icc()/Health-GettyImages-2153927815-0bf99cd73e2c46908d7fc0973739f6d0.jpg)
